Mounjaro (tirzepatide) is a prescription medicine that has gained attention as an option for medically supervised weight management. In this video, Dr. Vikram Lotwala, bariatric surgeon in Surat, explains the availability and role of Mounjaro Weight Loss Injection Now in India and how it may be considered as part of a personalized weight-management plan.
Mounjaro works on GIP and GLP-1 pathways involved in appetite regulation and metabolic control. By helping reduce appetite and increase feelings of fullness, tirzepatide may support weight loss in appropriately selected patients. However, Mounjaro is not a quick-fix treatment and is not suitable for everyone.
At Dr. Vikram Lotwala’s clinic in Surat, Gujarat, patients can undergo an individual medical assessment before starting weight-loss medication. Factors such as BMI, existing health conditions, current medications, previous weight-loss attempts and personal treatment goals can help determine whether medical weight management is appropriate.
How does Mounjaro work for weight loss?
Mounjaro contains tirzepatide, which activates two gut hormone receptors, GIP and GLP-1. This dual action reduces appetite, slows how quickly the stomach empties and improves how the body handles blood sugar, so you eat less without constant hunger.
This is what separates it from semaglutide medicines like Ozempic and Wegovy, which act on the GLP-1 receptor alone. The second receptor is the reason tirzepatide produced greater average weight loss in trials.
It is a once-weekly injection given under the skin of the abdomen, thigh or upper arm. The dose is increased gradually over several months rather than started at full strength.
How much weight can you lose with Mounjaro?
In the SURMOUNT-1 trial, adults with obesity lost an average of 15.0 percent of body weight at the 5 mg dose, 19.5 percent at 10 mg and 20.9 percent at 15 mg over 72 weeks, compared with 3.1 percent on placebo. Results depend on dose, consistency and diet.
| Weekly dose | Average total body weight loss at 72 weeks |
|---|---|
| 5 mg | 15.0 percent |
| 10 mg | 19.5 percent |
| 15 mg | 20.9 percent |
| Placebo | 3.1 percent |
You will often see a figure of 22.5 percent quoted. That comes from a separate analysis counting only people who stayed on treatment for the full period, so it is a best-case number rather than the average. Both figures are real. They answer different questions.
These results were achieved alongside diet and activity changes, not instead of them. Protein intake and resistance exercise matter, because rapid weight loss without them costs you muscle as well as fat.
Who is eligible for Mounjaro in India?
Mounjaro is approved in India for adults with type 2 diabetes, and for chronic weight management in adults with obesity or with overweight plus at least one weight-related condition such as hypertension, sleep apnoea, fatty liver or dyslipidaemia.
Indian BMI thresholds are lower than Western ones, because metabolic risk appears at a lower body weight in South Asian populations. In our clinic in Surat we regularly see patients with significant insulin resistance and fatty liver at a BMI that would be considered unremarkable in Europe or the United States. The WHO guidance on obesity and overweight reflects this ethnic variation in risk.
Mounjaro is generally not suitable if you:
- Have a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
- Have had pancreatitis
- Are pregnant, planning pregnancy, or breastfeeding
- Have severe gastrointestinal disease such as gastroparesis
- Want it for cosmetic weight loss at a normal BMI
What are the side effects of Mounjaro, and what tests do you need first?
The most common side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation and reduced appetite. These usually appear when the dose increases and settle within a few weeks. Slow titration, smaller meals and good hydration reduce them considerably.
Less common but more serious risks include pancreatitis, gallstones and gallbladder disease. Rapid weight loss from any cause, including surgery and dieting, raises gallstone risk, so this is not unique to the drug. Muscle loss is a real and underdiscussed risk when protein intake is inadequate.
Baseline and periodic tests your doctor should order:
- HbA1c and fasting blood sugar
- Kidney function tests
- Liver function tests
- Thyroid profile
- Serum lipase
- Lipid profile
If your prescriber has not asked for these, that is a warning sign about the quality of supervision, not a convenience.
How do you avoid counterfeit Mounjaro in India?
Counterfeit tirzepatide pens have appeared in the Indian market since the 2025 launch. Buy only from a licensed pharmacy that verifies your prescription, and treat any offer at a steep discount as a red flag rather than a bargain.
- Refuse anything sold without a prescription check. A legitimate seller cannot dispense a Schedule H medicine without one.
- Be suspicious of discounts beyond about 10 to 12 percent. Licensed online pharmacies discount modestly. Deep discounts are not how genuine cold-chain medicine is sold.
- Insist on refrigerated delivery. Tirzepatide requires cold-chain handling. If it arrives at room temperature, do not use it.
- Check the pack seal, batch number and expiry against the manufacturer’s details before the delivery person leaves.
- Never buy from social media sellers or unverified marketplaces.
What happens if you stop taking Mounjaro?
Weight regain is common after stopping Mounjaro. The medicine works by suppressing appetite signals while it is in your system, so appetite returns once you stop. Trial follow-up shows a substantial share of lost weight returns within roughly a year unless diet and exercise habits are firmly established.
This is not a failure of willpower. It is how the drug works, and it is why the decision to start should include a plan for what happens afterwards. Anyone starting a GLP-1 medicine should be clear about whether they intend it as a long-term therapy, a bridge to something else, or a short course.
Is Mounjaro a substitute for bariatric surgery?
Mounjaro is not a substitute for bariatric surgery in every case. It gives 15 to 21 percent average weight loss while continued. Bariatric surgery gives 25 to 35 percent that is largely durable long term. They suit different severities of the same disease.
Increasingly the two are used together rather than as rivals. Medication before surgery can reduce liver size and operative risk in higher BMI patients, and medication after surgery can help manage late weight regain. Which path suits you depends on your BMI, your comorbidities and what you can sustain financially and medically over years, not months.
For a side-by-side breakdown of both options, see our comparison of the best weight loss treatment in India, or read about laparoscopic sleeve gastrectomy and the non-surgical intragastric balloon.
Get Started With a Consultation Today
If you’re ready to take a step toward a healthier, more confident version of yourself – now is the time.
Reach out to Dr. Vikram Lotwala via:
- Phone: +91 9824437573 / +91 9909966056
- Email: doctorvikram@gmail.com
- Website: drvikramlotwala.com
Explore more about treatments, patient experiences, and recovery stories via:
Conclusion
If you are considering a Mounjaro weight loss injection in India or looking for medically supervised weight-loss treatment in Surat, professional evaluation is important. Watch the video to learn more about Mounjaro and discuss your individual options with a qualified doctor.
Book a consultation with Dr. Vikram Lotwala in Surat, Gujarat, to understand whether Mounjaro or another weight-management approach may be appropriate for you.
FAQs
1. What is Mounjaro weight loss injection?
Mounjaro contains tirzepatide, a prescription medicine that acts on GIP and GLP-1 pathways and may be used as part of medical weight management in appropriate patients.
2. Is Mounjaro weight loss injection now available in India?
Mounjaro is available in India as a prescription medicine. Its use for an individual patient should be determined by a qualified healthcare professional based on the applicable indication and medical assessment.
3. How does Mounjaro help with weight loss?
Tirzepatide can help regulate appetite and increase feelings of fullness, which may reduce food intake and support weight loss when used appropriately.
4. Who can take Mounjaro for weight loss?
Mounjaro is not suitable for everyone. A doctor may consider factors such as BMI, medical conditions, medications, treatment history and individual weight-management goals before prescribing it.
5. Is Mounjaro available for weight loss treatment in Surat?
Medical weight-management services involving Mounjaro are offered through Dr. Vikram Lotwala’s practice in Surat, Gujarat, subject to individual medical evaluation.
6. Is Mounjaro better than bariatric surgery?
Neither treatment is universally better. Medication and bariatric surgery have different indications, benefits and risks. The appropriate option depends on the patient’s health, BMI and treatment goals.
7. Can Mounjaro replace diet and exercise?
No. Prescription weight-loss medication works best as part of a comprehensive weight-management plan that may include nutrition, physical activity and ongoing medical monitoring.
8. Who should I consult before starting Mounjaro in India?
Consult a qualified doctor or obesity/bariatric specialist before starting Mounjaro. Dr. Vikram Lotwala provides medically supervised weight-management options in Surat.
